GSA Capital Partners LLP lowered its stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) by 36.8% during the third quarter, according to the company in its most recent disclosure with ...

Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. So, the natural question for Biomea Fusion (NASDAQ:BMEA) ...

On Tuesday, Truist Securities adjusted its stance on Biomea Fusion Inc. (NASDAQ:BMEA) stock, moving from a Buy to a Hold rating. This decision comes in the wake of a clinical hold... On Monday, H ...

On Thursday, Oppenheimer adjusted its outlook on Biomea Fusion Inc. (NASDAQ:BMEA), reducing its price target to $60 from the previous $70, while continuing to endorse the stock ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The U.S. Food and Drug Administration lifted a clinical hold on Biomea Fusion's ongoing studies of its experimental drug for type 1 and type 2 diabetes, the drug developer said on Thursday.

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

The two leaders will meet in Peru, where China has steadily expanded its influence in a challenge to the United States in its own region. By David Pierson and Mitra Taj Displaced young ...

Facing China, Trump to be “direct” in dealings with Africa Cameron Hudson talks about how Trump’s approach to competing with China in Africa will dramatically differ from Biden’s.